Business Update21 Jun 2024, 08:28 pm
AstraZeneca Pharma India Ltd. to Explore Buyer for Manufacturing Site Exit
AI Summary
AstraZeneca Pharma India Limited has completed the exploration phase for finding a Contract Manufacturing Organisation buyer and could not find a suitable one. The company will now explore a buyer for its manufacturing site and exit in due course. The company remains committed to advancing access to innovative medicines in India and transforming patient outcomes. The company's primary responsibility will be towards its employees and ensuring an uninterrupted supply of medicines to patients during this transition.
Key Highlights
- AstraZeneca Pharma India Ltd. could not find a suitable Contract Manufacturing Organisation buyer
- The company will explore a buyer for its manufacturing site and exit in due course
- Company remains committed to advancing access to innovative medicines in India
- Company's first responsibility is towards its employees and patients
- Company aims to ensure an uninterrupted supply of medicines during the transition